临床儿科杂志
臨床兒科雜誌
림상인과잡지
Journal of Clinical Pediatrics
2015年
9期
813-816
,共4页
梁云梅%吕燕松%张金%任思其%呙芳
樑雲梅%呂燕鬆%張金%任思其%咼芳
량운매%려연송%장금%임사기%괘방
髓母细胞瘤%小脑性缄默%儿童
髓母細胞瘤%小腦性緘默%兒童
수모세포류%소뇌성함묵%인동
medulloblastoma%cerebellar mutism%child
目的:探讨小脑性缄默(CM)与髓母细胞瘤(MB)复发及原发肿瘤位置的相关性。方法回顾性分析2011年11月至2015年4月收治的114例3岁以上MB患儿的临床资料。结果114例患儿中,男77例、女37例,初次发病中位年龄84.7月(36.4~184.7月),其中48例为复发病例。22例发生CM,发生率为19.3%(22/114);其中非复发及复发MB患儿CM发生率分别为19.7%(13/66)及18.8%(9/48),二者间差异无统计学意义(P=0.899);原发肿瘤位于第四脑室者的CM发生率17.6%(9/51),小脑蚓部为7.1%(1/14),第四脑室及小脑蚓部同时受累者21.4%(3/14),第四脑室合并其他部位受累者45.5%(5/11),小脑蚓部合并其他部位受累者50.0%(4/8),非第四脑室及小脑蚓部受累者无CM发生。CM发生率在原发肿瘤位置累及第四脑室和/或小脑蚓部与未累及第四脑室和/或小脑蚓部患儿间的差异有统计学意义(P=0.039)。结论 CM发生与MB患儿复发无相关性。原发肿瘤侵犯第四脑室和/或小脑蚓部者易发生CM。
目的:探討小腦性緘默(CM)與髓母細胞瘤(MB)複髮及原髮腫瘤位置的相關性。方法迴顧性分析2011年11月至2015年4月收治的114例3歲以上MB患兒的臨床資料。結果114例患兒中,男77例、女37例,初次髮病中位年齡84.7月(36.4~184.7月),其中48例為複髮病例。22例髮生CM,髮生率為19.3%(22/114);其中非複髮及複髮MB患兒CM髮生率分彆為19.7%(13/66)及18.8%(9/48),二者間差異無統計學意義(P=0.899);原髮腫瘤位于第四腦室者的CM髮生率17.6%(9/51),小腦蚓部為7.1%(1/14),第四腦室及小腦蚓部同時受纍者21.4%(3/14),第四腦室閤併其他部位受纍者45.5%(5/11),小腦蚓部閤併其他部位受纍者50.0%(4/8),非第四腦室及小腦蚓部受纍者無CM髮生。CM髮生率在原髮腫瘤位置纍及第四腦室和/或小腦蚓部與未纍及第四腦室和/或小腦蚓部患兒間的差異有統計學意義(P=0.039)。結論 CM髮生與MB患兒複髮無相關性。原髮腫瘤侵犯第四腦室和/或小腦蚓部者易髮生CM。
목적:탐토소뇌성함묵(CM)여수모세포류(MB)복발급원발종류위치적상관성。방법회고성분석2011년11월지2015년4월수치적114례3세이상MB환인적림상자료。결과114례환인중,남77례、녀37례,초차발병중위년령84.7월(36.4~184.7월),기중48례위복발병례。22례발생CM,발생솔위19.3%(22/114);기중비복발급복발MB환인CM발생솔분별위19.7%(13/66)급18.8%(9/48),이자간차이무통계학의의(P=0.899);원발종류위우제사뇌실자적CM발생솔17.6%(9/51),소뇌인부위7.1%(1/14),제사뇌실급소뇌인부동시수루자21.4%(3/14),제사뇌실합병기타부위수루자45.5%(5/11),소뇌인부합병기타부위수루자50.0%(4/8),비제사뇌실급소뇌인부수루자무CM발생。CM발생솔재원발종류위치루급제사뇌실화/혹소뇌인부여미루급제사뇌실화/혹소뇌인부환인간적차이유통계학의의(P=0.039)。결론 CM발생여MB환인복발무상관성。원발종류침범제사뇌실화/혹소뇌인부자역발생CM。
Objective To investigate the relationships among cerebellar mutism (CM), relapsed medulloblastoma (MB) and the primary tumor location.MethodsA retrospective analysis was conducted in 114 children over 3 years old with MB from November 2011 to April 2015.ResultsThe median onset age was 84.7 months (36.4 to 184.7 months) in 114 children with MB (77 boys and 37 girls), of whom there were 48 cases of recurrence. There were twenty two cases of CM and the overall incidence of CM was 19.3% (22/114). The incidence of CM was 19.7% (13/66) in non-recurrent cases and 18.8% (9/48) in recur-rent cases, and there was no signiifcant difference between two groups (P=0.899). The incidence of CM was 17.6% (9/51) in cas-es with primary tumor in the fourth ventricle, 7.1% (1/14) in cases with primary tumor in the cerebellar vermis, 21.4% (3/14) in cases with primary tumor in both fourth ventricle and cerebellar vermis, 45.5% (5/11) in cases with primary tumor in fourth ven-tricle and other parts of the brain, and 50.0% (4/8) in cases with primary tumor in cerebellar vermis and other parts of the brain. No CM incidence was observed in cases with primary tumor in central nerve system except for the fourth ventricle and cerebellar vermis. The incidence of CM between the cases with fourth ventricle/cerebellar vermis involvement and those without fourth ventricle/ cerebellar vermis involvement had signiifcant difference (P=0.039). ConclusionsThere is no relationship between CM and relapsed MB. Children with MB whose primary tumor is located in the fourth ventricle and/or the cerebellar vermis is susceptible to CM.